[4-(5-Aminothiazolo[5,4-d]pyrimidin-7-yl)piperazin-1-yl]-(1H-indol-2-yl)methanone

ID: ALA4218178

PubChem CID: 145969385

Max Phase: Preclinical

Molecular Formula: C18H17N7OS

Molecular Weight: 379.45

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Nc1nc(N2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)c2ncsc2n1

Standard InChI:  InChI=1S/C18H17N7OS/c19-18-22-15(14-16(23-18)27-10-20-14)24-5-7-25(8-6-24)17(26)13-9-11-3-1-2-4-12(11)21-13/h1-4,9-10,21H,5-8H2,(H2,19,22,23)

Standard InChI Key:  WPPOSOGWMNQIDJ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 31  0  0  0  0  0  0  0  0999 V2000
   29.8632  -23.0258    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.8621  -23.8453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5701  -24.2543    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.5683  -22.6169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2769  -23.0222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2818  -23.8453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0661  -24.0952    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   32.5461  -23.4263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0583  -22.7633    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.1540  -24.2533    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.5659  -21.7997    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.2743  -21.3897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2738  -20.5761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5667  -20.1658    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.8584  -20.5753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8572  -21.3951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5673  -19.3486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8599  -18.9394    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.2723  -18.9384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0185  -19.2713    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.3584  -18.1258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1578  -17.9564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5633  -18.6645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3748  -18.6673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7869  -17.9637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3814  -17.2556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5637  -17.2511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  2 10  1  0
  4 11  1  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 14 17  1  0
 17 18  2  0
 19 20  1  0
 20 23  1  0
 22 21  1  0
 21 19  2  0
 17 19  1  0
 22 23  2  0
 22 27  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4218178

    ---

Associated Targets(Human)

PI4KB Tchem PI4-kinase beta subunit (1593 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 379.45Molecular Weight (Monoisotopic): 379.1215AlogP: 2.11#Rotatable Bonds: 2
Polar Surface Area: 104.03Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.35CX LogP: 2.06CX LogD: 2.06
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.55Np Likeness Score: -1.50

References

1. Reuberson J, Horsley H, Franklin RJ, Ford D, Neuss J, Brookings D, Huang Q, Vanderhoydonck B, Gao LJ, Jang MY, Herdewijn P, Ghawalkar A, Fallah-Arani F, Khan AR, Henshall J, Jairaj M, Malcolm S, Ward E, Shuttleworth L, Lin Y, Li S, Louat T, Waer M, Herman J, Payne A, Ceska T, Doyle C, Pitt W, Calmiano M, Augustin M, Steinbacher S, Lammens A, Allen R..  (2018)  Discovery of a Potent, Orally Bioavailable PI4KIIIβ Inhibitor (UCB9608) Able To Significantly Prolong Allogeneic Organ Engraftment in Vivo.,  61  (15): [PMID:29952567] [10.1021/acs.jmedchem.8b00521]

Source